Systemic Sclerosis Sera Impair Angiogenic Performance of Dermal Microvascular Endothelial Cells: Therapeutic Implications of Cyclophosphamide

Elevated Levels of Pentraxin 3 in Systemic Sclerosis: Associations With Vascular Manifestations and Defective Vasculogenesis

(2015) Yuichiro Shirai et al.   Arthritis & Rheumatology

Autologous Mesenchymal Stem Cells Foster Revascularization of Ischemic Limbs in Systemic Sclerosis

(2013) Serena Guiducci et al.   ANNALS OF INTERNAL MEDICINE

Increased plasma levels of the VEGF165b splice variant are associated with the severity of nailfold capillary loss in systemic sclerosis

(2013) Mirko Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative

(2013) Frank van den Hoogen et al.   ANNALS OF THE RHEUMATIC DISEASES

Review: Evidence That Systemic Sclerosis Is a Vascular Disease

(2013) Marco Matucci-Cerinic et al.   ARTHRITIS AND RHEUMATISM

Dysregulation of angiogenic homeostasis in systemic sclerosis

(2013) Hanan Mohamed Farouk et al.   International Journal of Rheumatic Diseases

Epigenetic repression of bone morphogenetic protein receptor II expression in scleroderma

(2013) Yongqing Wang et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database

(2013) Francesca Ingegnoli et al.   MICROVASCULAR RESEARCH

Decreased expression of the endothelial cell-derived factor EGFL7 in systemic sclerosis: potential contribution to impaired angiogenesis and vasculogenesis

(2013) Mirko Manetti et al.   ARTHRITIS RESEARCH & THERAPY

Systemic sclerosis sera affect fibrillin-1 deposition by dermal blood microvascular endothelial cells: therapeutic implications of cyclophosphamide

(2013) Marilisa Villano et al.   ARTHRITIS RESEARCH & THERAPY

Brief Report: Impaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells in Patients With Systemic Sclerosis

(2013) Masataka Kuwana et al.   Arthritis & Rheumatology

Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage

(2012) Mirko Manetti et al.   ANNALS OF THE RHEUMATIC DISEASES

Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

(2012) Florian M P Meier et al.   ANNALS OF THE RHEUMATIC DISEASES

Bosentan fosters microvascular de-remodelling in systemic sclerosis

(2012) S. Guiducci et al.   CLINICAL RHEUMATOLOGY

Longterm Effects of Endothelin Receptor Antagonism on Microvascular Damage Evaluated by Nailfold Capillaroscopic Analysis in Systemic Sclerosis

(2012) M. CUTOLO et al.   JOURNAL OF RHEUMATOLOGY

Impaired Angiogenesis in Systemic Sclerosis: The Emerging Role of the Antiangiogenic VEGF165b Splice Variant

(2012) Mirko Manetti et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Angiogenic biomarkers predict the occurrence of digital ulcers in systemic sclerosis

(2011) Jérôme Avouac et al.   ANNALS OF THE RHEUMATIC DISEASES

Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells

(2011) Jérôme Avouac et al.   ARTHRITIS AND RHEUMATISM

Overexpression of VEGF 165 b, an Inhibitory Splice Variant of Vascular Endothelial Growth Factor, Leads to Insufficient Angiogenesis in Patients With Systemic Sclerosis

(2011) Mirko Manetti et al.   CIRCULATION RESEARCH

Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma

(2011) Hanadi Dib et al.   EUROPEAN RESPIRATORY JOURNAL

Dysregulated expression of MIG/CXCL9, IP-10/CXCL10 and CXCL16 and their receptors in systemic sclerosis

(2011) Bradley J Rabquer et al.   ARTHRITIS RESEARCH & THERAPY

Angiogenesis and Vasculopathy in Systemic Sclerosis: Evolving Concepts

(2011) Bradley J. Rabquer et al.   Current Rheumatology Reports

Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells

(2010) Boubacar Mariko et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Anti-endothelial cell antibodies in systemic sclerosis

(2010) C Mihai et al.   ANNALS OF THE RHEUMATIC DISEASES

Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12

(2010) Francesca Margheri et al.   ARTHRITIS AND RHEUMATISM

Mechanisms in the loss of capillaries in systemic sclerosis: angiogenesis versus vasculogenesis

(2010) Mirko Manetti et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Assessing microvascular changes in systemic sclerosis diagnosis and management

(2010) Maurizio Cutolo et al.   Nature Reviews Rheumatology

Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis

(2010) Y. Furuya et al.   RHEUMATOLOGY

Transforming growth factor-β1 causes pulmonary microvascular endothelial cell apoptosis via ALK5

(2009) Qing Lu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo

(2009) Jonathan Goldin et al.   CHEST

Immune cells and angiogenesis

(2009) Domenico Ribatti et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Abnormalities in the Regulators of Angiogenesis in Patients with Scleroderma

(2009) L. K. HUMMERS et al.   JOURNAL OF RHEUMATOLOGY

Scleroderma

(2009) Armando Gabrielli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autologous stem cell transplantation improves microcirculation in systemic sclerosis

(2008) I Miniati et al.   ANNALS OF THE RHEUMATIC DISEASES

Cyclophosphamide treatment improves microvessel damage in systemic sclerosis

(2008) Paola Caramaschi et al.   CLINICAL RHEUMATOLOGY

Capillary Regeneration in Scleroderma: Stem Cell Therapy Reverses Phenotype?

(2008) Jo N. Fleming et al.   PLoS One